NCT01133210View on ClinicalTrials.gov

Effect of Maraviroc on Metabolic Function in Obese Subjects (Phase I)

PHASE1CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

August 31, 2012

Study Completion Date

November 30, 2012

Conditions
Hypertriglyceridemia
Interventions
DRUG

Maraviroc

dosage will be a 300mg Maraviroc pill twice a day for 12 weeks

OTHER

placebo

subjects will be given placebo pills with instructions to take one pill twice a day for 12 weeks.

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Washington University School of Medicine

OTHER